# Coconut Oil Cognition Randomized Trial: What the Evidence Says Canonical: https://www.migaku.app/guides/coconut-oil-cognition-randomized-trial-evidence-review Category: evidence-review Summary: Coconut Oil Cognition Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are Last reviewed: 2026-06-27 Reviewed by: Migaku Evidence Review # Coconut Oil Cognition Randomized Trial: What the Evidence Says ## Quick Answer Coconut Oil Cognition Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, randomized trial, so conclusions should be framed as evidence-aware guidance rather than medical advice. ## Key Takeaways - This page is generated only from sources stored in the Migaku evidence knowledge base. - Current evidence mix: 1 systematic review, 1 randomized trial. - Claims should be interpreted with the source type, study design, population, and publication date in mind. - This article is educational and does not replace care from a qualified clinician. ## Evidence Map | Source | Evidence type | Level | Date | Identifier | | --- | --- | ---: | --- | --- | | The effect of exogenous ketone bodies on cognition across health and disease: a systematic review and meta-analysis | systematic review | 1 | 2026-04-15 | 10.3389/fnut.2026.1802531 | | Fat Amount Rather Than Fatty Acid Composition Influences Postprandial Hunger, Satiety and Attention in Men and Women with a Risk Phenotype for Cardiometabolic Diseases: A Randomized Crossover Trial | randomized trial | 2 | 2026-01-01 | 10.1016/j.tjnut.2025.11.003 | ## What The Sources Report - In addition to the reduced quality of life and wellbeing for the patient, ADRD also imposes a cost on society through the significant financial burden of patient care. [Bonnechère Bruno (2026); evidence level 1] - Furthermore, ≥2 of the following characteristics of metabolic syndrome had to apply:) dyslipidemia (serum triglycerides ≥1.7 mmol/L and/or serum HDL cholesterol <1.03 mmol/L for men and <1.29 mmol/L for women),) increased resting blood pressure (systolic BP ≥130 mmHg and/or diastolic BP ≥85 mmHg), and) increased plasma glucose (≥5.6 mmol/L). [Diekmann Christina (2026); evidence level 2] ## How To Read This Evidence Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade. ## Practical Interpretation There is at least one systematic-review style source in the current set, so it deserves more weight than single-study evidence. There is trial evidence in the current set, but population and intervention details still matter. For coconut oil cognition randomized trial, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence. ## Limits Of This First Pass This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review. ## References - Bonnechère Bruno (2026). The effect of exogenous ketone bodies on cognition across health and disease: a systematic review and meta-analysis. DOI: 10.3389/fnut.2026.1802531. PMCID: PMC13127162. PMID: 42063954. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13127162/ - Diekmann Christina (2026). Fat Amount Rather Than Fatty Acid Composition Influences Postprandial Hunger, Satiety and Attention in Men and Women with a Risk Phenotype for Cardiometabolic Diseases: A Randomized Crossover Trial. DOI: 10.1016/j.tjnut.2025.11.003. PMCID: PMC12881678. PMID: 41232773. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12881678/ ## Safety Note Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.